Abnormal expression of Pygo2 has been reported in several cancers such as breast cancer, glioma, esophageal squamous cell carcinoma, hepatocellular carcinoma and prostate cancer 7, 13, 14, 16, 33-35. Here, PYGO2 is linked to hepatocellular carcinoma.